Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

REVIVA PHARMACEUTICALS HOLDINGS, INC.

(RVPH)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Reviva Pharmaceuticals Holdings, Inc., formerly Tenzing Acquisition Corp., is a holding company. The Company, through its subsidiary Reviva Pharmaceuticals, Inc, is principally engaged in developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), cardiovascular, metabolic, and inflammatory diseases. The Company's pipeline has two drug candidates, RP5063 (Brilaroxazine) and RP1208. Its primary focus is developing its lead product candidate, RP5063, for the treatment of schizophrenia, bipolar disorder, major depressive disorder, behavioral and psychotic symptoms. It also intends to develop RP5063 for treating pulmonary arterial hypertension and idiopathic pulmonary fibrosis. RP5063 is a serotonin, dopamine, and nicotinic receptor active compound in clinical development. The Company's RP1208 is a novel triple reuptake inhibitor, which is engaged in enabling studies for depression and animal efficacy studies for obesity.

Number of employees : 5 people.
Managers
Name Title Age Since
Laxminarayan Bhat, Dr. President, Chief Executive Officer & Director 55 2020
Narayan Prabhu Chief Financial Officer 49 2020
Marcus Cantillon, Dr. Chief Medical Officer 62 2020
Parag Phoolchand Saxena Chairman 65 2020
Richard A. Margolin, Dr. Independent Director 70 2020
Leslie David Funtleyder Independent Director 50 2020
Purav Patel Independent Director 37 2020
Members of the board
Name Title Age Since
Parag Phoolchand Saxena Chairman 65 2020
Laxminarayan Bhat, Dr. President, Chief Executive Officer & Director 55 2020
Richard A. Margolin, Dr. Independent Director 70 2020
Leslie David Funtleyder Independent Director 50 2020
Purav Patel Independent Director 37 2020
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 13,388,986 7,999,888 59.7% 0 0.0% 59.7%
Shareholders
NameEquities%
Laxminarayan Bhat 2,484,244 18.6%
Vedanta Capital LLC 2,300,876 17.2%
Tang Capital Management LLC 1,200,000 8.96%
Tenzing LLC 970,876 7.25%
Hudson Bay Capital Management LP 810,000 6.05%
Armistice Capital LLC 714,700 5.34%
Glazer Capital LLC 707,617 5.29%
BMO Asset Management Corp. 694,065 5.18%
The Vanguard Group, Inc. 527,608 3.94%
Rahul Nayar 515,651 3.85%
Brand Portfolio
In partnership withAllbrands.markets
More brands of Reviva Pharmaceuticals Holdings, Inc.